Total Payments
$2,641
2024 Payments
$1,608
Companies
18
Transactions
108
Medicare Patients
450
Medicare Billing
$48,143
Payment Breakdown by Category
Food & Beverage$2,616 (99.1%)
Education$24.61 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,616 | 107 | 99.1% |
| Education | $24.61 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $599.52 | 23 | $0 (2024) |
| Amgen Inc. | $394.59 | 16 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $197.55 | 12 | $0 (2024) |
| NxStage Medical, Inc. | $184.89 | 3 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $180.70 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $171.87 | 9 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $131.95 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.51 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $113.47 | 6 | $0 (2024) |
| Vifor Pharma, Inc. | $103.05 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,608 | 71 | AstraZeneca Pharmaceuticals LP ($332.07) |
| 2023 | $948.32 | 33 | AstraZeneca Pharmaceuticals LP ($267.45) |
| 2022 | $83.93 | 4 | Vifor Pharma, Inc. ($25.07) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Catheter Lock Solution | ||||||
| 12/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/11/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Catheter Lock Solution | ||||||
| 12/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEPHROLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.22 | General |
| 11/12/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Hyperkalemia | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Rare Disease | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Nephrology | ||||||
| 10/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Nephrology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEPHROLOGY | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: NEPHROLOGY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $31.01 | General |
| 08/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Nephrology | ||||||
| 08/20/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 353 | 619 | $126,400 | $42,312 |
| 2022 | 2 | 75 | 80 | $15,823 | $4,959 |
| 2021 | 1 | 11 | 42 | $630.00 | $261.66 |
| 2020 | 1 | 11 | 13 | $3,068 | $610.45 |
Total Patients
450
Total Services
754
Medicare Billing
$48,143
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 281 | $49,300 | $14,025 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 202 | $40,400 | $13,354 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 92 | 118 | $29,500 | $11,884 | 40.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 18 | $7,200 | $3,049 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 56 | $10,075 | $3,861 | 38.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 24 | $5,748 | $1,098 | 19.1% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 11 | 42 | $630.00 | $261.66 | 41.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 13 | $3,068 | $610.45 | 19.9% |
About An Lam
An Lam is a Nurse Practitioner healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1457826067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, An Lam has received a total of $2,641 in payments from pharmaceutical and medical device companies, with $1,608 received in 2024. These payments were reported across 108 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,616).
As a Medicare-enrolled provider, Lam has provided services to 450 Medicare beneficiaries, totaling 754 services with total Medicare billing of $48,143. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Gulfport, MS
- Active Since 10/10/2018
- Last Updated 10/10/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1457826067
Products in Payments
- FARXIGA (Drug) $309.68
- LOKELMA (Drug) $289.84
- TAVNEOS (Drug) $245.34
- RAYALDEE (Drug) $197.55
- NXSTAGE SYSTEM ONE (Device) $184.89
- JYNARQUE (Drug) $171.87
- Velphoro (Drug) $116.67
- Kerendia (Drug) $113.47
- Auryxia (Drug) $107.34
- Veltassa (Drug) $103.05
- INSPIRE (Device) $97.17
- Parsabiv (Drug) $89.00
- DefenCath (Drug) $83.42
- ULTOMIRIS (Biological) $63.60
- Aranesp (Biological) $60.25
- LUPKYNIS (Drug) $56.43
- ACTHAR (Biological) $30.26
- Vafseo (Drug) $24.61
- TERLIVAZ (Drug) $23.38
- MONOFERRIC (Drug) $22.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Gulfport
Rebecca Ramirez, Np, NP
Nurse Practitioner — Payments: $20,807
Nurse Practitioner $20,807
Mariah Cox, Np, NP
Nurse Practitioner — Payments: $8,282
Nurse Practitioner $8,282
Jared Deloach, Np, NP
Nurse Practitioner — Payments: $4,350
Nurse Practitioner $4,350
Brenda Bennett, Cfnp, CFNP
Nurse Practitioner — Payments: $4,286
Nurse Practitioner $4,286
Matt Gatlin
Nurse Practitioner — Payments: $3,851
Nurse Practitioner $3,851
Mrs. Julie Ainsworth, Np, NP
Nurse Practitioner — Payments: $3,839
Nurse Practitioner $3,839